$0.077900
-0.08-98.72%
At close: Jul 23, 9:34 AM EDT
15 minutes delayed
Comments
Loading...
Navidea Biopharmaceutical
NAVBOTCEM
Navidea Biopharmaceutical (OTC:NAVB) Stock, Earnings Estimates, EPS, And Revenue
Navidea Biopharmaceutical reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Nov 14
EPS
$-0.020
Quarterly Revenue
$0K
Annual Revenue
(as of Sep 30)
(as of Sep 30)
$0.6K
Analyze the earnings history of Navidea Biopharmaceutical using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| NAVB | Navidea Biopharmaceutical | -$0.03 | — | — | — | $0.00 | — | — | — | 08/09/2024 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.25 | — | -$0.02 | — | $7.52K | — | $0.00 | — | 11/14/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.10 | — | -$0.03 | — | $57.53K | — | $0.00 | — | 08/11/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.10 | — | -$0.09 | — | $0.00 | — | $0.00 | — | 05/11/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.12 | — | -$0.11 | — | $50.35K | — | $610.00 | — | 03/21/2023 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.08 | — | -$0.25 | — | $96.38K | — | $7.52K | — | 11/14/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.09 | — | -$0.10 | — | $261.05K | — | $57.53K | — | 08/15/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.11 | — | -$0.10 | — | $123.74K | — | $0.00 | — | 05/12/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.11 | — | -$0.12 | — | $219.25K | — | $50.35K | — | 03/23/2022 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.13 | -$0.11 | -$0.08 | 27.27% | $268.39K | — | $96.38K | — | 11/10/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.11 | -$0.08 | -$0.09 | -12.50% | $271.10K | — | $261.05K | — | 08/11/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.13 | -$0.08 | -$0.12 | -50.00% | $156.27K | — | $123.74K | — | 05/11/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.15 | -$0.12 | -$0.11 | 8.33% | $119.30K | $600.00K | $219.25K | -63.46% | 03/24/2021 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.17 | -$0.09 | -$0.13 | -44.44% | $236.81K | $150.00K | $268.39K | 78.93% | 11/12/2020 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.24 | — | -$0.11 | — | $260.09K | $156.00K | $271.10K | 73.78% | 08/13/2020 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.24 | — | -$0.13 | — | $136.03K | — | $156.27K | — | 05/14/2020 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.40 | -$0.12 | -$0.15 | -25.00% | $119.32K | — | $119.30K | — | 03/11/2020 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.40 | -$0.17 | -$0.17 | 0.00% | $231.46K | — | $236.81K | — | 11/07/2019 | Get Alert |
| NAVB | Navidea Biopharmaceutical | -$0.40 | — | -$0.24 | — | $542.13K | — | $260.09K | — | 08/08/2019 | Get Alert |
Navidea Biopharmaceutical (NAVB) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Sep 2021 | 2021-11-10 | $-0.08 | $-0.11 | 27.3 % |
| Jun 2021 | 2021-08-11 | $-0.09 | $-0.08 | -12.5 % |
| Mar 2021 | 2021-05-11 | $-0.12 | $-0.08 | -50.0 % |
| Dec 2020 | 2021-03-24 | $-0.11 | $-0.12 | 8.33 % |
Navidea Biopharmaceutical (NAVB) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Dec 2020 | 2021-03-24 | $219.25K | $600.00K | -63.5 % |
| Sep 2020 | 2020-11-12 | $268.39K | $150.00K | 78.9 % |
| Jun 2020 | 2020-08-13 | $271.10K | $156.00K | 73.8 % |
FAQ
When is Navidea Biopharmaceutical (OTCEM:NAVB) reporting earnings?
Navidea Biopharmaceutical (NAVB) is scheduled to report earnings on August 9, 2024. The last reported earnings were for reported on November 14, 2023 for Q3.
What were the latest earnings per share (EPS) for Navidea Biopharmaceutical (OTCEM:NAVB)?
The Actual EPS was $-0.02, which missed the estimate of $0.00.
What were Navidea Biopharmaceutical’s (OTCEM:NAVB) revenues?
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.